These compounds are not specific inhibitors of NOXA1 but have been shown to affect the NOX complex or ROS production, which is the primary function of NOXA1. By hindering the NOX complex formation or function, these compounds could indirectly reduce the activity of NOXA1.
Inhibitors associated with NOXA1, as outlined in the table, would target the broader NOX complex or ROS production pathways. NOXA1 is a critical regulator of the NOX complex, which is a significant source of ROS in non-phagocytic cells. These ROS play essential roles in cell signaling and homeostasis but can also contribute to pathological states when overproduced. By modulating the NOX complex's activity, the inhibitors could indirectly influence NOXA1's function, thereby regulating ROS levels within cells. This approach could impact various cellular responses where NOXA1 and NOX-derived ROS are involved. The detailed effects of these compounds on NOXA1 and the NOX complex's regulatory mechanisms would require further empirical validation to elucidate their specificity and the exact mode of action.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Apocynin | 498-02-2 | sc-203321 sc-203321A sc-203321B sc-203321C | 1 g 10 g 100 g 500 g | $27.00 $68.00 $116.00 $360.00 | 74 | |
Inhibits the assembly of NOX complex components, which might affect NOXA1 function in ROS production. | ||||||
VAS-2870 | 722456-31-7 | sc-471103 | 10 mg | $124.00 | ||
A pan-NOX inhibitor that prevents NOX-mediated ROS production, potentially impacting NOXA1's role in NOX complex activation. | ||||||
2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione | sc-501137 | 25 mg | $380.00 | |||
A dual NOX1/NOX4 inhibitor that might indirectly inhibit NOXA1 by blocking NOX1 complex activity. | ||||||
2-Acetylphenothiazine | 6631-94-3 | sc-223384 sc-223384A | 25 g 100 g | $74.00 $222.00 | ||
Selective NOX1 inhibitor that may indirectly affect NOXA1 by inhibiting the NOX1-dependent ROS generation. | ||||||
Diphenyleneiodonium chloride | 4673-26-1 | sc-202584E sc-202584 sc-202584D sc-202584A sc-202584B sc-202584C | 10 mg 25 mg 50 mg 100 mg 250 mg 500 mg | $151.00 $136.00 $317.00 $405.00 $944.00 $1837.00 | 24 | |
A flavoprotein inhibitor that can inhibit NOX enzymes, thereby potentially affecting NOXA1 activity. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
An irreversible serine protease inhibitor that can also inhibit NOX activity, indirectly affecting NOXA1 function. | ||||||
Plumbagin | 481-42-5 | sc-253283 sc-253283A | 100 mg 250 mg | $52.00 $62.00 | 6 | |
A quinone that inhibits NOX activity, potentially modulating NOXA1's role in the complex. | ||||||
Ebselen | 60940-34-3 | sc-200740B sc-200740 sc-200740A | 1 mg 25 mg 100 mg | $33.00 $136.00 $458.00 | 5 | |
A seleno-organic compound that has antioxidant properties and may indirectly affect NOXA1 by reducing ROS levels. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
A xanthine oxidase inhibitor that reduces ROS production, which could lead to an indirect effect on NOXA1 activity. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Inhibitors of HMG-CoA reductase that have been shown to decrease NOX-derived ROS, possibly affecting NOXA1. | ||||||